Description: AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Home Page: www.angiodynamics.com
ANGO Technical Analysis
14 Plaza Drive
Latham,
NY
12110
United States
Phone:
518 795 1400
Officers
Name | Title |
---|---|
Mr. James C. Clemmer | CEO, Pres & Director |
Mr. Stephen A. Trowbridge | Exec. VP & CFO |
Mr. David D. Helsel | Sr. VP of Global Operations and R&D |
Mr. Chad T. Campbell | Sr. VP & GM of Vascular Access Global Bus. Unit |
Ms. Laura Piccinini | Sr. VP & GM of International |
Mr. Richard C. Rosenzweig | Sr. VP, Gen. Counsel & Company Sec. |
Mr. Benjamin H. Davis | Sr. VP of Bus. Devel. |
Ms. Marna I. Bronfen-Moore | Sr. VP of HR |
Mr. Warren G. Nighan | Sr. VP of Quality & Regulatory Affairs |
Ms. Kim L. Seabury | Sr. VP of Information Technology |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 1111.1111 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.1873 |
Price-to-Sales TTM: | 1.4776 |
IPO Date: | 2004-05-27 |
Fiscal Year End: | May |
Full Time Employees: | 760 |